Trainline Raises Fiscal Year Guidance Again as Travel Demand Surges DBS CEO Tan Su Shan Clinches 6th Place on Fortunes 2026 Most Powerful Women List Temasek CFO Also Recognized Market Rally Highlights Portfolio Winners and Laggards Over Recent Six Weeks US Consumer Price Index Rises 38 Annually in April Exceeding Expectations Fresh US Military Strikes Raise Uncertainties for Iran Nuclear Diplomacy Virgin Galactic Q1 2026 Earnings Loss Narrows as Company Reports BetterThanExpected EPS MUR Q1 2026 Earnings Earnings Per Share Surpass Expectations Amid Volatile Oil Markets First Seacoast Bancorp FSEA Q3 2024 Earnings Modest Profit Despite Quiet Quarter SILC Q1 2026 Earnings Narrower Loss Than Expected Drives Stock Higher ADT Q1 2026 Earnings EPS Beats Estimates by 102 as Stock Edges Lower Tennessee Valley Authority TVE Edges Higher Approaching Resistance at 2477 Mesabi Trust MSB Edges Higher Holds Above Key Support Level NPACU Units Trade Flat as Support Holds Steady Near 10 Level Manhattan Bridge Capital LOAN Slips 047 Consolidation Near Support Level WaterBridge Infrastructure WBI Slides 5 Key Support Test in Play Dollar Tree DLTR Gains 219 as Discount Sector Resilience Drives Investor Interest Wealthtech Innovation Overload Financial Advisors Grapple with Tech Complexity Clear Channel Outdoor Holdings CCO Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Discipline China Industrial Profits Surge 247 in April Marking Fastest Growth in Over Two Years Biodexa Pharmaceuticals BDRX Edges Higher Amid Consolidation Near Key Support AllianceBernstein Holding AB Narrows Near Support After Slight Decline AppFolio Inc APPF Edges Higher as Stock Holds Above Key Support Neurocrine Biosciences NBIX Edges Higher Testing Key Resistance Zone ITHAX Acquisition Corp III Units ITHAU Holds Steady Near Trust Value as Market Awaits Business Combination CXApp Inc CXAI Surges 21 as Shares Test Key Resistance Level Falcons Beyond Global Warrants Hold Steady at 237 as Market Awaits Catalyst FBYDW GameStop GME Dips 14 as Trading Volume Remains Subdued Jade Biosciences JBIO Advances 275 as Stock Approaches Critical Resistance Goldman Sachs Flags Trade Policy Uncertainty and Sticky Inflation as Key Market Risks HOTH Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Holds Steady Nathans Famous NATH Holds Steady Near 101 Amid Minor Decline Support Levels in Focus